Abstract
This study evaluated the effect of argon laser iridoplasty (ALI) on 11 eyes with primary chronic angle closure glaucoma (CACG). All eyes had an intraocular pressure greater than 20 mmHg despite maximum medical therapy and were followed up for six months after ALI. Iridoplasty successfully opened at least half of the angle in all eyes, maximally reducing the intraocular pressure (IOP) in all eyes in the first week (paired t test p < 0.002). At three months, the IOP in 7 eyes were medically controlled while 4 eyes required trabeculectomy. The results at six months showed no further changes. Iridoplasty may be useful for lowering IOP in CACG and avoiding the need for surgery for up to six months in 64% of the eyes studied.
Similar content being viewed by others
References
Lim ASM, Tan A, Chew P. et al Laser iridoplasty in the treatment of severe acute angle closure glaucoma. International Ophthalmology 1993; 17:33-6.
Chew P, Chee C, Lim ASM. Laser treament of severe acute angle closure glaucoma in dark Asian indes: the role of iridoplasty. Lasers and Light in Ophthalmology 1991; 4 (2): 41–2.
Ritch R. Argon laser treatment of medically unresponsive attacks of angle-closure glaucoma. Am J Ophthalmol 1982; 94: 197.
Lowe RF Primary creeping angle closure glaucoma. Br J Ophthalmol 1964; 48: 544.
Chandler PA, Grant WM. Glaucoma, 2nd edition. Lea and Febiger, Philadelphia, 1979.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chew, P.T.K., Yeo, L.M.W. Argon laser iridoplasty in chronic angle closure glaucoma. Int Ophthalmol 19, 67–70 (1995). https://doi.org/10.1007/BF00133174
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00133174